Mohd H. Abdul‐Aziz

Author

Mohd H. Abdul‐Aziz

Also Known As

Abdul-Aziz Mohd Hafiz, Abdulaziz M., Da Dalt S, M Abdulaziz, M. ABDULAZIZ, M. Abdul-Aziz, M. Abdulaziz, M. Hafiz Abdul-Aziz, M.H. Abdul-Aziz, Maryam Hassan Abdulaziz

100

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

The University of Queensland Royal Brisbane and Women's Hospital Queensland University of Technology Université de Nîmes Université de Montpellier

About

Mohd H. Abdul‐Aziz is an author at The University of Queensland specializing in medicine, drug resistance, and antimicrobial pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	601
2	Critical Care Medicine	4	4	457
3	Health Sciences	2	2	65
4	Public Health	1	1	20
5	Anesthesia	1	1	113

Mohd H. Abdul‐Aziz

Publications

Citations

H-Index

Page 1

	Year	Citations
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis Mohd H. Abdul‐Aziz, Helmi Sulaiman, Mohd Basri Mat Nor, Intensive Care Medicine Critical Care MedicineSevere SepsisControlled TrialAcute CarePatient Safety	2016	310
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort Mohd H. Abdul‐Aziz, Jeffrey Lipman, Murat Akova, Journal of Antimicrobial Chemotherapy	2015	157
Continuous beta-lactam infusion in critically ill patients: the clinical evidence Mohd H. Abdul‐Aziz, Joel M. Dulhunty, Rinaldo Bellomo, Annals of Intensive Care PharmacotherapyDrug ResistanceContinuous Beta-lactam InfusionCritical Care MedicineSepsis	2012	113
Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Mohd H. Abdul‐Aziz, Christine E. Staatz, Carl M. J. Kirkpatrick, PubMed Therapeutic Drug MonitoringAntimicrobial StewardshipAntibioticsPharmacodynamicsMedicine	2012	59
What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients? Abdulaziz S. Alobaid, Alexander Brinkmann, Otto Frey, Journal of Antimicrobial Chemotherapy	2015	56
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation Kiran Shekar, Mohd H. Abdul‐Aziz, Vesa Cheng, American Journal of Respiratory and Critical Care Medicine	2022	52
Impairment of Long-Term Potentiation in the CA1, But Not Dentate Gyrus, of the Hippocampus in Obese Zucker Rats: Role of Calcineurin and Phosphorylated CaMKII Karem H. Alzoubi, Mohd H. Abdul‐Aziz, Aleisa Aleisa, Journal of Molecular Neuroscience Synaptic PlasticityNeurophysiologyNeuroanatomyMedicinePhysiology	2005	45
Increasing ventilator surge capacity in COVID 19 pandemic: design, manufacture and in vitro–in vivo testing in anaesthetized healthy pigs of a rapid prototyped mechanical ventilator Jayesh Dhanani, George Pang, Jason Pincus, BMC Research Notes	2020	31
Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range. Mohd H. Abdul‐Aziz, Kara Brady, Menino Osbert Cotta, PubMed	2022	28
Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study) Vesa Cheng, Mohd H. Abdul‐Aziz, Fay Burrows, International Journal of Antimicrobial Agents Critical Care ManagementCritical Care MedicineAcute CareAsap Ecmo StudyPopulation Pharmacokinetics	2021	21

Page 1